Kai Biotech (446600) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Kai Biotech is dated 2024-05-03; the most recent is 2024-09-12. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2024-09-12 | BUY | 장외매수 | 새한산업 Saehan Industry | - | 136.4K | ₩6,340 | +136.6% | ₩865M ($600K) |
| 2024-05-03 | BUY | 장외매수 | 김영덕 Youngdeok Kim | CEO | 45.5K | ₩6,340 | +136.6% | ₩288M ($200K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Kai Biotech. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.